• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Stereotactic body radiation therapy for hepatic malignancies: Organs at risk, uncertainties margins, doses].

作者信息

Lacornerie T, Rio E, Mahé M-A

机构信息

Service de physique médicale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille, France.

Service de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Professeur-Jacques-Monod, 44805 Saint-Herblain, France.

出版信息

Cancer Radiother. 2017 Oct;21(6-7):574-579. doi: 10.1016/j.canrad.2017.07.028. Epub 2017 Aug 24.

DOI:10.1016/j.canrad.2017.07.028
PMID:28844506
Abstract

Stereotactic body radiation therapy for primary and metastatic hepatic malignancies can be performed in association and/or as an alternative to surgery and radiofrequency. The consequences of the great number of techniques available are heterogeneity in contouring, dose prescription and in determination of dose constraints for organs at risk. The objective of this paper is to improve the quality and safety and to help the diffusion of this technique for a majority of patients. In 2016, the French Society of Radiation Oncology (SFRO) published guidelines for external radiotherapy and brachytherapy ("Recorad"). This paper is an update of these recommendations considering recent publications.

摘要

相似文献

1
[Stereotactic body radiation therapy for hepatic malignancies: Organs at risk, uncertainties margins, doses].
Cancer Radiother. 2017 Oct;21(6-7):574-579. doi: 10.1016/j.canrad.2017.07.028. Epub 2017 Aug 24.
2
[Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].[适形和立体定向体部放射治疗中危及器官的剂量：肝脏]
Cancer Radiother. 2017 Oct;21(6-7):604-612. doi: 10.1016/j.canrad.2017.07.042.
3
[Delineation of organs at risk and dose constraints].[危及器官的勾画与剂量限制]
Cancer Radiother. 2016 Sep;20 Suppl:S36-60. doi: 10.1016/j.canrad.2016.07.032. Epub 2016 Aug 8.
4
[Stereotactic body radiation therapy in the management of liver tumours].[立体定向体部放射治疗在肝脏肿瘤治疗中的应用]
Cancer Radiother. 2014 Oct;18(5-6):486-94. doi: 10.1016/j.canrad.2014.07.145. Epub 2014 Sep 5.
5
[Hepatic tumors and radiotherapy].[肝脏肿瘤与放射治疗]
Cancer Radiother. 2016 Sep;20 Suppl:S174-8. doi: 10.1016/j.canrad.2016.07.019. Epub 2016 Aug 9.
6
Hepatic tumours and radiotherapy.肝脏肿瘤与放射治疗。
Cancer Radiother. 2022 Feb-Apr;26(1-2):266-271. doi: 10.1016/j.canrad.2021.08.013. Epub 2021 Dec 23.
7
[Stereotactic body radiotherapy. How to better protect normal tissues?].[立体定向体部放射治疗。如何更好地保护正常组织？]
Cancer Radiother. 2019 Oct;23(6-7):630-635. doi: 10.1016/j.canrad.2019.07.153. Epub 2019 Aug 22.
8
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].[肝脏立体定向体部放射治疗：临床特征、技术影响及结果。何种情况下使用何种治疗设备？]
Cancer Radiother. 2019 Oct;23(6-7):636-650. doi: 10.1016/j.canrad.2019.07.159. Epub 2019 Aug 20.
9
[Which constraints for which organs at risk in radiotherapy for adult patients?].
Cancer Radiother. 2015 Oct;19(6-7):479-83. doi: 10.1016/j.canrad.2015.05.013. Epub 2015 Aug 14.
10
[Doses to organs at risk for conformational and stereotactic radiotherapy: Bladder].
Cancer Radiother. 2017 Oct;21(6-7):597-603. doi: 10.1016/j.canrad.2017.07.038. Epub 2017 Sep 4.

引用本文的文献

1
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma.使用容积调强弧形放疗（VMAT）和实时自适应肿瘤门控技术的图像引导肝脏立体定向体部放疗：肝细胞癌疗效和毒性评估
Cancers (Basel). 2021 Sep 28;13(19):4853. doi: 10.3390/cancers13194853.